Warfarin anticoagulation after total hip or total knee replacement: Clinical and resource-utilization outcomes in a university-based antithrombosis clinic

American Journal of Health-System Pharmacy

Volumn 70, Issue 5, 2013, Pages 423-430

  Nutescu, Edith A ^a   Bautista, Adriana ^a   Gao, Weihua ^b   Galanter, William L ^c,d   Schumock, Glen T ^a   Mody, Samir H ^e   Bookhart, Brahim K ^f   Lambert, Bruce L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Center for Clinical and Translational Science   (United States)

^c Cleveland Clinic Lerner   (United States)

^d Department of Pharmacy Practice   (United States)

^e Translational Science Team   (United States)

^f JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; WARFARIN;

ACUTE DISEASE; ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; BODY MASS; CANCER THERAPY; CENTRAL VENOUS CATHETERIZATION; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; ENTERITIS; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GENETIC DISORDER; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INJURY; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; LENGTH OF STAY; LIVER DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MYELOPROLIFERATIVE DISORDER; NEOPLASM; NEPHROTIC SYNDROME; ORAL CONTRACEPTION; OUTPATIENT; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATIENT MONITORING; PHYSICAL DISABILITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; POSTPARTUM HEMORRHAGE; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL PATIENT; THROMBOPHILIA; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT DURATION; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84874069684     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp120341     Document Type: Article

References (25)

1. Lee K, Goodman SB. Current state and future of joint replacements in the hip and knee. Expert Rev Med Devices. 2008; 5:383-93.
2. DeFrances CJ, Lucas CA, Buie VC et al. 2006 National Hospital Discharge Survey. Natl Health Stat Rep. 2008; 5:1-20.
3. Kurtz S, Mowat F, Ong K et al. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am. 2005; 87:1487-97.
4. Kurtz S, Ong K, Lau E et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007; 89:780-5.
5. Pulido L, Parvizi J, Macgibeny M et al. In hospital complications after total joint arthroplasty. J Arthroplasty. 2008; 23:139-45.
6. Geerts WH, Bergqvist D, Pineo GF et al. Prevention of venous thromboembo-lism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008; 133(suppl):381S-453S.
7. MacDougall DA, Feliu AL, Boccuzzi SJ et al. Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Am J Health-Syst Pharm. 2006; 63(suppl 6):S5-15.
8. Guyatt GH, Akl EA, Crowther M et al. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012; 141:7S-47S.
9. American Academy of Orthopedic Surgeons. Guideline on preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. www.aaos.org/research/guidelines/VTE/VTE-guideline.asp (accessed 2012 Jul 10).
10. Brotman DJ, Jaffer AK, Hurbanek JG et al. Warfarin prophylaxis and venous throm-boembolism in the first 5 days following hip and knee arthroplasty. Thromb Haemost. 2004; 92:1012-7.
11. Caprini JA, Arcelus JI, Motykie G et al. The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement. J Vasc Surg. 1999; 30:813-20.
12. Tufano A, Coppola A, Cerbone AM et al. Preventing postsurgical venous thrombo-embolism: pharmacological approaches. Semin Thromb Hemost. 2011; 37:252-66.
13. Friedman RJ, Gallus AS, Cushner FD et al. Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty. Curr Med Res Opin. 2008; 24:87-97.
14. Mesko JW, Brand RA, Iorio R et al. Venous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients: a survey of the AAHKS membership. J Arthroplasty. 2001; 16:679-88.
15. Nutescu EA, Shorr AF, Farrelly E et al. Burden of deep vein thrombosis in the outpatient setting following major orthopedic surgery. Ann Pharmacother. 2008; 42:1216-21.
16. Menzin J, Boulanger L, Hauch O et al. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study. Ann Pharmacother. 2005; 39:446-51.
17. Witt DM, Sadler MA, Shanahan RL et al. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest. 2005; 127:1515-22.
18. Nutescu EA. Anticoagulation management services: entering a new era. Pharmacotherapy. 2010; 30:327-9.
19. Nochowitz B, Shapiro NL, Nutescu EA et al. Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population. Ann Pharmacother. 2009; 43:1165-72.
20. Hamby L, Weeks WB, Malikowski C. Complications of warfarin therapy: causes, costs, and the role of the anticoagulation clinic. Eff Clin Pract. 2000; 3:179-84.
21. Phillips KW, Ansell J. Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management. Expert Rev Cardiovasc Ther. 2008; 6:57-70.
22. Rose AJ, Berlowitz DR, Frayne SM et al. Measuring quality of oral anticoagulation care: extending quality measurement to a new field. Jt Comm J Qual Patient Saf. 2009; 35:146-55.
23. Nordstrom BL, Kachroo S, Fraeman KH et al. Warfarin prophylaxis in patients after total knee or hip arthroplasty - International Normalized Ratio patterns and venous thromboembolism. Curr Med Res Opin. 2011; 27:1973-85.
24. Balcom WB, Mishol DN, Eapen S et al. A single-center experience with low-dose warfarin in patients undergoing total hip or knee replacement surgery. Curr Orthop Pract. 2012; 23:221-8.
25. Baker WL, Cios DA, Sander SD et al. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm. 2009; 15:244-52.